Advertisement

International Viral Hepatitis Elimination Meeting (IVHEM) 2023


We are proud to announce that the International Viral Hepatitis Elimination Meeting (IVHEM) 2023 will take place as a hybrid meeting from 1 to 2 December 2023 in Amsterdam, the Netherlands! Convened by Academic Medical Education and the Coalition for Global Hepatitis Elimination (CGHE), IVHEM is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress towards the elimination of viral hepatitis as a public health threat by 2030. Hepatitis B and C affect more than 354 million people globally and can lead to liver disease and mortality from liver failure and hepatocellular carcinoma. More than 296 million people (3.7% of the world’s population) live with HBV, and over 820,000 deaths are attributable annually. An estimated 58 million people (globally, 0.73%) live with the hepatitis C virus (HCV), resulting in nearly 290,000 deaths annually. Key issues to be addressed are how to translate research outcomes into public health policy and practice to meet the 2030 elimination targets. During this two-day meeting, experts in viral hepatitis from around the globe will examine current evidence on how to implement programs that improve the prevention of viral hepatitis and increase the number of people accessing testing and treatment. The program includes practical examples of innovative intervention studies, country elimination programs, and novel funding mechanisms for testing and treatment.

When
December 1 ‐ December 2, 2023
Location
Amsterdam, the Netherlands
Venue
Amsterdam Marriott Hotel
Link

Map

loading...

GET DIRECTIONS

Advertisement

Hot topics


Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Hep uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.